Non-canonical NLRC4 inflammasomes in astrocytes contribute to glioma malignancy.

The present study was designed to explore the pathological role of non-canonical NLRC4 inflammasome in glioma. This retrospective study included bioinformatical analysis, including survival, gene ontology, ssGSEA, cox regression, IPA and drug repositioning with TCGA and DepMap database. Experimental validations were conducted in glioma patient's sample and evaluated with histological or cellular functional analysis. Clinical dataset analysis revealed that non-canonical NLRC4 inflammasomes significantly contribute to glioma progression and poor survival rates. Experimental validation was revealed that the expression of non-canonical NLRC4 inflammasomes were co-localized with astrocytes in malignant gliomas, with a sustained clinical correlation observed between astrocytes and inflammasome signatures. Indeed, the formation of an inflammatory microenvironment increased in malignant gliomas, leading to pyroptosis, known as inflammatory cell death. Molecular interaction analysis revealed that NF-κB pathways potentially serve as the connecting point between the canonical and noncanonical pathways of the NLRC4 inflammasome. Finally, drug repositioning analysis of non-canonical NLRC4 inflammasome-associated molecules revealed that MK-5108, PF4981517, and CTEP may represent effective options for glioma therapy. The findings of this study suggest that non-canonical NLRC4 inflammasomes contribute to poor prognosis in patients with glioma and induce an inflammatory microenvironment. We propose the pathological phenomenon of non-canonical NLRC4 inflammasomes and several therapeutic strategies based on the modulation of the inflammatory tumor microenvironment. © 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Citation

JeongMin Sim, Ju Won Ahn, JeongMan Park, Yu Jin Kim, Ju-Yeon Jeong, Ji Min Lee, Kyunggi Cho, Hee Jung Ahn, Kyoung Su Sung, Jong-Seok Moon, Ju Hyung Moon, Jaejoon Lim. Non-canonical NLRC4 inflammasomes in astrocytes contribute to glioma malignancy. Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 2023 Apr;72(4):813-827

Mesh Tags

Substances

PMID: 36899084

search → result